Virtual Event | December 19, 2022

Questions from the Cell & Gene Live Audience

Source: Cytiva

During Cell & Gene Live events, we take real-time questions from our audience. Here, Gregory Opiteck, Ph.D., VP Head of Translational Sciences at Allogene Therapeutics and Douglas Sanders, Ph.D., VP Head of Translational Medicine at AVROBIO provide thoughtful, detailed responses to our audience’s questions, including how maneuver a company's infrastructure in order for the biomarker translational groups to collaborate better as well as how to evolve translational approaches in the cell and gene therapy space more confidently into the clinic.

access the Virtual Event!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene